Role of the angiotensin AT1 receptor in rat aortic and cardiac PAI-1 gene expression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2297-2302

  Chen, Hong Chi ^a   Bouchie, Julie L ^a   Perez, Alexandra S ^a   Clermont, Allen C ^a   Izumo, Seigo ^a   Hampe, James ^a   Feener, Edward P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Angiotensin II; Aorta; Hypertension; Plasminogen activator inhibitor; Vascular smooth muscle cells

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN[1-7]; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HEART MUSCLE CELL; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033786487     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.10.2297     Document Type: Article

References (39)

1. Plasminogen activator inhibitor type 1: Biochemistry and evidence for modulation of fibrinolysis in vivo
2. Plasminogen activator inhibitors: A review
3. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
4. Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis
5. Association of blood pressure with fibrinolytic potential in the Framingham offspring population
6. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
7. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension
8. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells
9. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
10. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells
11. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells
12. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta
13. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction
14. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1
15. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure
16. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension
17. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension
18. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta
19. Mechanism of protective effects of ACE inhibition on coronary artery disease
20. Angiotensin receptors: Molecular biology and signalling
21. Angiotensin II receptors
22. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle
23. 4 receptor
24. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells
25. Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
26. Candesartan: A new-generation angiotensin II AT1 receptor blocker: Pharmacology, antihypertensive efficacy, renal function, and renoprotection
27. 1 receptor subtype
28. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells: Role of cGMP in the regulation of the plasminogen system
29. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR
30. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense
31. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors
32. The renin-angiotensin system and its receptors
33. Kidney aminopeptidase A and hypertension, part I: Spontaneously hypertensive rats
34. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II
35. Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction
36. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats
37. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats
38. Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: Effects of losartan
39. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat